Starting weight, body fat percentage, training history, hormonal status, sleep quality, stress levels, and dose all create different timelines
"I love that it's just a capsule-no needles, no powders, no sketchy sourcing
Mixing medications without studies backing their safety can be risky
Li N, Liu R-J, Dwyer JM, Banasr M, Lee B, Son H, et al
The guideline is designed as a living document that will be updated as new real-world and long-term evidence emerges. In effect, the WHO is saying: the benefits are real, but we must continue to study safety, durability, and what happens when treatment stops. Where there is evidence for GLP-1 efficacy and safety, the WHO notes that existing studies are at serious risk of bias and are of either low or very low quality
Managing Treatment Costs Managing the costs associated with GLP-1 treatments involves strategic planning and transparent partnerships